In vitro human serum albumin glycation monitored by Terahertz spectroscopy

The nonenzymatic attachment of sugars to proteins, namely glycation, is accelerated under diabetic conditions. Monitoring the glycated human serum albumin (HSA) levels gives the short term variation of glucose concentration in diabetic patients blood. Therefore, a significant effort was made to measure glycated HSA, including by spectroscopic methods such as Raman. Here we used THz spectroscopy to monitor HSA glycation in time (over 5, 7 and 11 weeks). Different sugar types have different reactivity; therefore we also addressed the reducing sugar influence on glycation by performing in vitro HSA glycation by both glucose and fructose. Since residues protonation state influences their susceptibility for glycation, we incubated HSA with sugars at two pH values: 7 and 8. Our results show that THz absorption decreases with the incubation time of HSA with sugars. At the incubation times we considered, the most significant differences were obtained on HSA samples glycated using glucose. Differences between samples glycated by glucose and by fructose show that glycation by glucose is a slower process. At pH 7, glycation by glucose is slower than at pH 8, while glycation by fructose is slightly faster at pH 7 than at pH 8. Glycated HSA models with different degrees of glycation were built by molecular modeling. Simulated THz spectra of the models are in good agreement with the experimental data. All these show that THz spectroscopy could monitor the progression of glycation in time and that it is sensitive to reducing sugars or pH value used in the glycation process.

[1]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[2]  R. Flückiger,et al.  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. , 1986, The Journal of biological chemistry.

[3]  A. Oronsky,et al.  Nonenzymatic glycation of bovine serum albumin by fructose (fructation). Comparison with the Maillard reaction initiated by glucose. , 1989, The Journal of biological chemistry.

[4]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[5]  Paul J Thornalley,et al.  Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. , 2002, The Biochemical journal.

[6]  R. Dasari,et al.  Raman Spectroscopy Provides a Powerful Diagnostic Tool for Accurate Determination of Albumin Glycation , 2012, PloS one.

[7]  H. V. Roohk,et al.  A Review of Glycated Albumin as an Intermediate Glycation Index for Controlling Diabetes , 2008, Journal of diabetes science and technology.

[8]  J. Chan,et al.  Combined Use of a Fasting Plasma Glucose Concentration and HbA1c or Fructosamine Predicts the Likelihood of Having Diabetes in High-Risk Subjects , 1998, Diabetes Care.

[9]  I. Macdonald,et al.  Some effects, in man, of varying the load of glucose, sucrose, fructose, or sorbitol on various metabolites in blood. , 1978, The American journal of clinical nutrition.

[10]  L. Bry,et al.  Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. , 2001, Clinical chemistry.

[11]  T. Harada,et al.  Glycated Albumin Induces Activation of Activator Protein-1 in Retinal Glial Cells , 2007, Japanese Journal of Ophthalmology.

[12]  L. Bonfante,et al.  Mass spectrometric study of in vivo production of advanced glycation end-products/peptides. , 2005, Journal of mass spectrometry : JMS.

[13]  D. S. Hage,et al.  Quantitative analysis of glycation sites on human serum albumin using (16)O/(18)O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[14]  E. Bourdon,et al.  Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. , 2006, Biochimie.

[15]  C. Watała [Role of nonenzymatic glycosylation of proteins in disorders of erythrocytes and blood platelets in diabetes mellitus]. , 1993, Acta haematologica Polonica.

[16]  E. Bourdon,et al.  The glycation of albumin: structural and functional impacts. , 2011, Biochimie.

[17]  A. Nègre-Salvayre,et al.  Hyperglycemia and glycation in diabetic complications. , 2009, Antioxidants & redox signaling.

[18]  D. Galton,et al.  Sorbitol and other polyols in lens, adipose tissue and urine in diabetes mellitus. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[19]  Y. Sanejouand,et al.  Building‐block approach for determining low‐frequency normal modes of macromolecules , 2000, Proteins.

[20]  R. Bucala,et al.  Immunochemical detection of advanced glycosylation end products in vivo. , 1992, The Journal of biological chemistry.

[21]  D. Kitts,et al.  Physiological and pharmacological properties of maillard reaction products. , 2003 .

[22]  William Clarke,et al.  Comparison of modification sites formed on human serum albumin at various stages of glycation. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[23]  I B Lamster,et al.  Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. , 2000, Periodontology 2000.

[24]  T. Dascălu,et al.  Validation of protein structural models using THz spectroscopy: a promising approach to solve three-dimensional structures , 2014 .

[25]  Omar St. Aubyn Barnaby,et al.  Characterization of Glycation Sites on Human Serum Albumin using Mass Spectrometry , 2010 .

[26]  J. Uitto,et al.  Nonenzymatic glycosylation of collagen and other proteins: relationship to development of diabetic complications. , 1982, Collagen and related research.

[27]  M. Leone,et al.  Thermal aggregation of glycated bovine serum albumin. , 2010, Biochimica et biophysica acta.

[28]  K. Tomer,et al.  Effect of nonenzymatic glycation of albumin and superoxide dismutase by glucuronic acid and suprofen acyl glucuronide on their functions in vitro. , 1999, Chemico-biological interactions.

[29]  S. Curry,et al.  Lessons from the crystallographic analysis of small molecule binding to human serum albumin. , 2009, Drug metabolism and pharmacokinetics.

[30]  M. Inaba,et al.  Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes , 2008, Clinical endocrinology.

[31]  J. N. Fisher,et al.  Hyperglycemic Crises in Adult Patients With Diabetes , 2009, Diabetes Care.

[32]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[33]  Qibin Zhang,et al.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. , 2009, Journal of proteome research.

[34]  J. Baynes,et al.  13C NMR investigation of nonenzymatic glucosylation of protein. Model studies using RNase A. , 1983, The Journal of biological chemistry.

[35]  A. Uno,et al.  Effects of glycosylation of hypoglycaemic drug binding to serum albumin , 1997, Biopharmaceutics & drug disposition.

[36]  Wenjun Zheng,et al.  Evidence of protein collective motions on the picosecond timescale. , 2010, Biophysical journal.

[37]  Jan H. Jensen,et al.  Very fast empirical prediction and rationalization of protein pKa values , 2005, Proteins.

[38]  K. Gabbay,et al.  Mechanism of development and possible prevention of sugar cataracts. , 1972, Israel journal of medical sciences.

[39]  B. Ettinger,et al.  Comparison of serum fructosamine vs glycohemoglobin as measures of glycemic control in a large diabetic population , 1998, Acta Diabetologica.

[40]  C. Zheng,et al.  Glycated albumin in diabetic patients with chronic kidney disease. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[41]  Alexander D. MacKerell,et al.  Improved treatment of the protein backbone in empirical force fields. , 2004, Journal of the American Chemical Society.

[42]  N. J. Harrick,et al.  Internal reflection spectroscopy , 1968 .

[43]  K. Kobayashi,et al.  Crystal structure of human serum albumin at 2.5 A resolution. , 1999, Protein engineering.

[44]  E. Bourdon,et al.  The antioxidant properties of serum albumin , 2008, FEBS letters.

[45]  Andrea Markelz,et al.  THz time domain spectroscopy of biomolecular conformational modes. , 2002, Physics in medicine and biology.

[46]  S. Seifter,et al.  The nonenzymatic glycosylation of collagen. , 1983, Archives of biochemistry and biophysics.

[47]  Alexander D. MacKerell,et al.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. , 2012, Journal of chemical theory and computation.

[48]  R Balu,et al.  Terahertz spectroscopy of bacteriorhodopsin and rhodopsin: similarities and differences. , 2008, Biophysical journal.

[49]  R. Birge,et al.  Photoactive Yellow Protein Terahertz Response: Hydration, Heating and Intermediate States , 2013, IEEE Transactions on Terahertz Science and Technology.

[50]  Toru Maruyama,et al.  The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. , 2003, Biochimica et biophysica acta.

[51]  D. S. Hage,et al.  Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[52]  D. S. Hage,et al.  Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS. , 2011, Clinica chimica acta; international journal of clinical chemistry.